USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark RETIGEN was filed as Word mark on 11/03/2004 at the U.S. Patent and Trademark Office. The current status of the mark is "ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE".
| Trademark form | Word mark |
| File reference | 78510542 |
| Application date | November 3, 2004 |
Trademark owner
202, 279 Midpark Way S.E.
T2X 1M2 Calgary
CA
T2X 1M2 Calgary
CA
Trademark representatives
goods and services
5
PHARMACEUTICAL DRUGS AND DRUG TREATMENTS, AND INFORMATIONAL MATERIALS TO ASSIST IN THE TREATMENT AND UNDERSTANDING OF OCULAR DISEASE, INCLUDING MACULAR DEGENERATION AND DIABETIC RETINOPATHY; AND ITS SIDE EFFECTS
35
THE DEVELOPMENT, MANUFACTURE, ADMINISTRATION, SALE AND DISTRIBUTION OF PHARMACEUTICAL DRUGS AND DRUG TREATMENTS, AND INFORMATIONAL MATERIALS RELATING TO THE TREATMENT AND UNDERSTANDING OF OCULAR DISEASE, INCLUDING MACULAR DEGENERATION AND DIABETIC RETINOPATHY; AND ITS SIDE EFFECTS
ID: 1378510542